| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.
|
Circulation
|
2011
|
6.36
|
|
2
|
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
|
N Engl J Med
|
2007
|
6.31
|
|
3
|
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2003
|
5.38
|
|
4
|
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
JAMA
|
2002
|
4.91
|
|
5
|
The 6-min walk test: a quick measure of functional status in elderly adults.
|
Chest
|
2003
|
4.29
|
|
6
|
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
|
JAMA
|
2002
|
3.88
|
|
7
|
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.
|
J Am Coll Cardiol
|
2006
|
3.25
|
|
8
|
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
|
Ann Intern Med
|
2007
|
3.13
|
|
9
|
Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.
|
Circulation
|
2007
|
3.11
|
|
10
|
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure.
|
J Am Coll Cardiol
|
2012
|
3.03
|
|
11
|
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.
|
Circulation
|
2012
|
2.95
|
|
12
|
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study.
|
Eur Heart J
|
2006
|
2.67
|
|
13
|
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.
|
Circulation
|
2007
|
2.62
|
|
14
|
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
|
J Am Coll Cardiol
|
2006
|
2.57
|
|
15
|
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.
|
J Am Coll Cardiol
|
2007
|
2.49
|
|
16
|
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
|
Clin J Am Soc Nephrol
|
2007
|
2.26
|
|
17
|
Retracted
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
|
J Clin Endocrinol Metab
|
2008
|
2.21
|
|
18
|
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
|
Menopause
|
2011
|
2.06
|
|
19
|
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.
|
Circulation
|
2006
|
2.03
|
|
20
|
Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease.
|
Heart Lung
|
2002
|
1.85
|
|
21
|
Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data.
|
BMJ
|
2011
|
1.73
|
|
22
|
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
|
J Am Coll Cardiol
|
2008
|
1.73
|
|
23
|
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.
|
Circulation
|
2010
|
1.73
|
|
24
|
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
|
Psychosom Med
|
2009
|
1.70
|
|
25
|
Outcomes at one-year follow-up of women and men with coronary artery disease discharged from cardiac rehabilitation: what benefits are maintained?
|
J Cardiopulm Rehabil Prev
|
2007
|
1.58
|
|
26
|
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
|
J Womens Health (Larchmt)
|
2004
|
1.57
|
|
27
|
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
Circulation
|
2009
|
1.54
|
|
28
|
Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.48
|
|
29
|
Optimizing risk stratification in cardiac rehabilitation with inclusion of a comorbidity index.
|
J Cardiopulm Rehabil
|
2004
|
1.47
|
|
30
|
Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
|
Arch Gen Psychiatry
|
2009
|
1.45
|
|
31
|
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
|
J Am Coll Cardiol
|
2003
|
1.44
|
|
32
|
Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.
|
Am J Cardiol
|
2004
|
1.43
|
|
33
|
Dietitian services are associated with improved patient outcomes and the MEDFICTS dietary assessment questionnaire is a suitable outcome measure in cardiac rehabilitation.
|
J Am Diet Assoc
|
2005
|
1.42
|
|
34
|
Depression, the metabolic syndrome and cardiovascular risk.
|
Psychosom Med
|
2007
|
1.41
|
|
35
|
Risk factor control for coronary artery disease secondary prevention in large randomized trials.
|
J Am Coll Cardiol
|
2013
|
1.40
|
|
36
|
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.
|
J Am Coll Cardiol
|
2009
|
1.40
|
|
37
|
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
|
Circulation
|
2002
|
1.34
|
|
38
|
The 6-minute walk test: how important is the learning effect?
|
Am Heart J
|
2003
|
1.27
|
|
39
|
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.
|
Am J Cardiol
|
2013
|
1.24
|
|
40
|
Increasing referral and participation rates to outpatient cardiac rehabilitation: the valuable role of healthcare professionals in the inpatient and home health settings: a science advisory from the American Heart Association.
|
Circulation
|
2012
|
1.22
|
|
41
|
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
|
JACC Cardiovasc Imaging
|
2010
|
1.21
|
|
42
|
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.
|
J Womens Health (Larchmt)
|
2011
|
1.21
|
|
43
|
Menopause, age, and cardiovascular risk: a complex relationship.
|
J Am Coll Cardiol
|
2009
|
1.21
|
|
44
|
Knowledge of heart attack symptoms in 20 US communities. Results from the Rapid Early Action for Coronary Treatment Community Trial.
|
Prev Med
|
2004
|
1.21
|
|
45
|
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
J Am Coll Cardiol
|
2009
|
1.16
|
|
46
|
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.
|
J Cardiopulm Rehabil Prev
|
2007
|
1.14
|
|
47
|
Social networks and incident stroke among women with suspected myocardial ischemia.
|
Psychosom Med
|
2008
|
1.14
|
|
48
|
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study.
|
J Am Coll Cardiol
|
2006
|
1.12
|
|
49
|
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study.
|
Am Heart J
|
2006
|
1.11
|
|
50
|
Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
|
Circulation
|
2007
|
1.10
|
|
51
|
Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study.
|
J Am Coll Cardiol
|
2009
|
1.10
|
|
52
|
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
|
Ann Intern Med
|
2005
|
1.07
|
|
53
|
Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
|
Fertil Steril
|
2006
|
1.06
|
|
54
|
The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
|
Ann Epidemiol
|
2005
|
1.02
|
|
55
|
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.
|
Circulation
|
2013
|
1.02
|
|
56
|
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
J Womens Health (Larchmt)
|
2009
|
1.00
|
|
57
|
Personal, social, and physical environmental correlates of physical activity in rural African-American women in Alabama.
|
Am J Prev Med
|
2003
|
0.99
|
|
58
|
The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
|
Diabetes Care
|
2004
|
0.98
|
|
59
|
Menopause and cardiovascular risk cause or consequence?
|
J Am Coll Cardiol
|
2006
|
0.97
|
|
60
|
Isolated diastolic hypotension and incident heart failure in older adults.
|
Hypertension
|
2011
|
0.96
|
|
61
|
Migraines, angiographic coronary artery disease and cardiovascular outcomes in women.
|
Am J Med
|
2006
|
0.95
|
|
62
|
Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).
|
Am Heart J
|
2013
|
0.94
|
|
63
|
Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial.
|
Am Heart J
|
2003
|
0.94
|
|
64
|
Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
|
Am J Cardiol
|
2010
|
0.94
|
|
65
|
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
|
J Clin Endocrinol Metab
|
2008
|
0.93
|
|
66
|
Factors associated with the failure of patients to complete cardiac rehabilitation for medical and nonmedical reasons.
|
J Cardiopulm Rehabil
|
2003
|
0.92
|
|
67
|
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?
|
J Womens Health (Larchmt)
|
2008
|
0.92
|
|
68
|
Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
|
J Womens Health (Larchmt)
|
2013
|
0.92
|
|
69
|
Women in cardiac rehabilitation: outcomes and identifying risk for dropout.
|
Am Heart J
|
2005
|
0.91
|
|
70
|
Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
|
Psychosom Med
|
2010
|
0.90
|
|
71
|
Prehospital delay in individuals with acute coronary disease: concordance of medical records and follow-up phone interviews.
|
Cardiology
|
2002
|
0.89
|
|
72
|
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
J Clin Endocrinol Metab
|
2010
|
0.89
|
|
73
|
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
|
J Am Heart Assoc
|
2014
|
0.89
|
|
74
|
Self-rated health among women with coronary disease: depression is as important as recent cardiovascular events.
|
Am Heart J
|
2006
|
0.88
|
|
75
|
Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study.
|
J Womens Health (Larchmt)
|
2006
|
0.88
|
|
76
|
Racial differences of lipoprotein subclass distributions in postmenopausal women.
|
Ethn Dis
|
2008
|
0.87
|
|
77
|
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study.
|
Psychosom Med
|
2012
|
0.87
|
|
78
|
Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation.
|
Am Heart J
|
2005
|
0.87
|
|
79
|
Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.
|
Thromb Haemost
|
2015
|
0.86
|
|
80
|
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
|
J Transl Med
|
2008
|
0.86
|
|
81
|
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
|
Cardiovasc Diagn Ther
|
2013
|
0.86
|
|
82
|
Cardiac rehabilitation outcomes: impact of comorbidities and age.
|
J Cardiopulm Rehabil Prev
|
2011
|
0.86
|
|
83
|
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).
|
Am J Cardiol
|
2008
|
0.86
|
|
84
|
Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.
|
Int J Cardiol
|
2009
|
0.85
|
|
85
|
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
|
Int J Cardiol
|
2013
|
0.85
|
|
86
|
The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association.
|
Circulation
|
2015
|
0.84
|
|
87
|
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.
|
Int J Cardiol
|
2013
|
0.84
|
|
88
|
Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
|
Am Heart J
|
2010
|
0.84
|
|
89
|
Biomarkers of atherosclerosis: clinical applications.
|
Curr Cardiol Rep
|
2008
|
0.83
|
|
90
|
The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials.
|
Thromb Haemost
|
2015
|
0.83
|
|
91
|
Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women.
|
J Gen Intern Med
|
2008
|
0.83
|
|
92
|
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
|
Womens Health (Lond Engl)
|
2013
|
0.83
|
|
93
|
Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
|
Am Heart J
|
2003
|
0.83
|
|
94
|
Cardiac rehabilitation and women: what keeps them away?
|
J Cardiopulm Rehabil Prev
|
2010
|
0.82
|
|
95
|
Phytoestrogens and lipoproteins in women.
|
J Clin Endocrinol Metab
|
2006
|
0.82
|
|
96
|
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
J Womens Health (Larchmt)
|
2008
|
0.82
|
|
97
|
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.
|
J Clin Endocrinol Metab
|
2010
|
0.81
|
|
98
|
Baseline differences in the HF-ACTION trial by sex.
|
Am Heart J
|
2009
|
0.81
|
|
99
|
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).
|
Am J Cardiol
|
2008
|
0.80
|
|
100
|
Physical activity patterns among women in rural Alabama.
|
Am J Health Behav
|
2003
|
0.80
|
|
101
|
Angina pectoris: reversal of the gender gap.
|
Circulation
|
2008
|
0.80
|
|
102
|
Women's angiographic vitamin and estrogen trial: design and methods.
|
Control Clin Trials
|
2002
|
0.79
|
|
103
|
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial).
|
Am J Cardiol
|
2011
|
0.79
|
|
104
|
Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
|
Curr Atheroscler Rep
|
2015
|
0.79
|
|
105
|
Assessing patient recall of discharge instructions for acute myocardial infarction.
|
J Healthc Qual
|
2009
|
0.79
|
|
106
|
Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
|
Prev Cardiol
|
2009
|
0.78
|
|
107
|
Secondary prevention outcomes among black and white cardiac rehabilitation patients.
|
Am Heart J
|
2007
|
0.78
|
|
108
|
Comparison of baseline characteristics and outcomes in younger and older patients completing cardiac rehabilitation.
|
J Cardiopulm Rehabil Prev
|
2009
|
0.78
|
|
109
|
LDL Lowering After Acute Coronary Syndrome: Is Lower Better?
|
Curr Treat Options Cardiovasc Med
|
2013
|
0.78
|
|
110
|
Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study.
|
BMC Health Serv Res
|
2014
|
0.77
|
|
111
|
Practical interpretation of 6-minute walk data using healthy adult reference equations.
|
J Cardiopulm Rehabil
|
2006
|
0.77
|
|
112
|
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: a statement for health care professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.
|
J Cardiopulm Rehabil Prev
|
2012
|
0.77
|
|
113
|
Drugs are not enough: the metabolic syndrome--a call for intensive therapeutic lifestyle change.
|
J Cardiometab Syndr
|
2009
|
0.77
|
|
114
|
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).
|
Menopause
|
2016
|
0.77
|
|
115
|
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
|
Am J Cardiol
|
2011
|
0.76
|
|
116
|
Depression and heart failure in patients with a new myocardial infarction.
|
Am Heart J
|
2005
|
0.76
|
|
117
|
Reply: To PMID 23177293.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
118
|
Exercise testing in heart failure: maximal, submaximal, or both?
|
J Am Coll Cardiol
|
2003
|
0.75
|
|
119
|
Cardiac rehabilitation: call to action for healthcare providers.
|
Circulation
|
2012
|
0.75
|
|
120
|
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study.
|
J Womens Health (Larchmt)
|
2009
|
0.75
|
|
121
|
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study.
|
Menopause
|
2016
|
0.75
|
|
122
|
Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
|
J Womens Health (Larchmt)
|
2007
|
0.75
|
|
123
|
Association of Internet Use With the Use of Addictive Substances in The United States.
|
Am J Cardiol
|
2020
|
0.75
|
|
124
|
Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
|
J Clin Lipidol
|
2007
|
0.75
|
|
125
|
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.
|
J Clin Lipidol
|
2010
|
0.75
|
|
126
|
Exercise as a treatment for the risk of cardiovascular disease.
|
Curr Treat Options Cardiovasc Med
|
2010
|
0.75
|
|
127
|
Transthoracic echocardiography guided procedures in the catheterization laboratory.
|
Echocardiography
|
2007
|
0.75
|
|
128
|
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE).
|
Am J Med
|
2002
|
0.75
|
|
129
|
Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction.
|
Curr Cardiol Rep
|
2015
|
0.75
|
|
130
|
Task force 10: training in preventive cardiovascular medicine.
|
J Am Coll Cardiol
|
2008
|
0.75
|
|
131
|
COCATS 4 Task Force 2: Training in Preventive Cardiovascular Medicine.
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
132
|
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: a statement for health care professionals from the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.
|
Circulation
|
2012
|
0.75
|